Related Experiment Video
Updated: Jun 8, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Chemopreventive potential of natural compounds in head and neck cancer
Mohammad Aminur Rahman1, A R M Ruhul Amin, Dong M Shin
1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) is one of the most fatal cancers worldwide. Despite advances in the management of HNSCC, the overall survival for patients has not improved significantly due to advanced stages at diagnosis, high recurrence rate after surgical removal, and second primary tumor development, which underscore the importance of novel strategies for cancer prevention. Cancer chemoprevention, the use of natural or synthetic compounds to prevent, arrest, or reverse the process of carcinogenesis at its earliest stages, aims to reverse premalignancies and prevent second primary tumors. Genomics and proteomics information including initial mutation, cancer promotion, progression, and susceptibility has brought molecularly targeted therapies for drug development. The development of preventive approaches using specific natural or synthetic compounds, or both, requires a depth of understanding of the cross-talk between cancer signaling pathways and networks to retain or enhance chemopreventive activity while reducing known toxic effects. Many natural dietary compounds have been identified with multiple molecular targets, effective in the prevention and treatment of cancer. This review describes recent advances in the understanding of the complex signaling networks driving cancer progression and of molecularly targeted natural compounds under preclinical and clinical investigation.
Insights
Novel strategies are crucial for preventing head and neck squamous cell carcinoma (HNSCC) due to high mortality and recurrence. This review explores molecularly targeted natural compounds for cancer chemoprevention, aiming to reverse premalignancies and prevent new tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Prevention
Background:
- Head and neck squamous cell carcinoma (HNSCC) remains a leading cause of cancer death globally.
- Current HNSCC management faces challenges including late diagnosis, post-surgical recurrence, and secondary tumors.
- Effective cancer chemoprevention strategies are needed to reverse premalignancies and prevent new cancer development.
Purpose of the Study:
- To review recent advances in understanding cancer signaling networks in HNSCC.
- To explore molecularly targeted natural compounds for cancer chemoprevention.
- To identify compounds with potential for preventing HNSCC and secondary tumors.
Main Methods:
- Literature review of preclinical and clinical studies on HNSCC.
- Analysis of genomics and proteomics data related to carcinogenesis.
- Investigation of natural dietary compounds and their molecular targets.
Main Results:
- Complex signaling pathways drive HNSCC progression.
- Many natural compounds exhibit chemopreventive properties by targeting multiple molecular pathways.
- Understanding pathway cross-talk is key to optimizing chemopreventive efficacy and reducing toxicity.
Conclusions:
- Molecularly targeted natural compounds show promise for HNSCC chemoprevention.
- Further research into signaling networks and compound interactions is essential.
- Developing effective preventive strategies can improve patient outcomes and reduce cancer burden.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

